This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
Google and Internet Privacy (A)
Harris, Jared D.; Denoncour, Joan; Heffernan, Edward; Koranne, Rahul; Marxen, Jake; Neu, Thomas; Sundaresan, Narayanan; Bowie, Norman E.; Mead, JennyCase DARDEN-E-0344-EBusiness Ethics and Corporate Social ResponsibilityBased on their use of a shared computer and the Internet ads that keep popping up, two co-workers suspect that another co-worker is HIV-positive or has AIDS. Using this story platform, the case explores Internet marketing, especially the powerhouse search engine Google and how it tracks its users’ habits. The history of Google is chronicled, as well as the privacy issues that have mushroomed as the Internet and its technology have developed.Starting at €8.20
-
Google and Internet Privacy (B)
Harris, Jared D.; Denoncour, Joan; Heffernan, Edward; Koranne, Rahul; Marxen, Jake; Neu, Thomas; Sundaresan, Narayanan; Bowie, Norman E.; Mead, JennyTechnical Note DARDEN-E-0345-EBusiness Ethics and Corporate Social ResponsibilityThis case begins with the resolution of the A case (disturbed by the office reaction to him, Patton resigns), and then discusses the privacy issues in the situation from a Utilitarian and a Kantian perspective.Starting at €8.20
-
Cipla 2011 (Spanish version)
Deshpande, Rohit; Sucher, Sandra J.; Winig, LauraCase HBS-517S04Business Ethics and Corporate Social ResponsibilityDr. Yusuf Hamied, head of the Indian pharma and generics manufacturing company Cipla, is weighing options for how to continue to support the global fight against HIV/AIDS while positioning his company for growth in a changing regulatory landscape.Starting at €8.20
-
Cipla 2011
Deshpande, Rohit; Sucher, Sandra J.; Winig, LauraCase HBS-511050-EBusiness Ethics and Corporate Social ResponsibilityDr. Yusuf Hamied, head of the Indian pharma and generics manufacturing company Cipla, is weighing options for how to continue to support the global fight against HIV/AIDS while positioning his company for growth in a changing regulatory landscape.Starting at €8.20